Conversely, it has been shown that Aβ plaques promote the development of cortical αSyn lesions in individuals with Parkinson’s disease (PD), and up to 50% of PD with dementia patients develop Aβ and tau pathology sufficient for a secondary pathological diagnosis of AD [19, 46]. Here, MAPT is linked to Parkinson disease.